The most-read First Opinion essays of 2022; an Aduhelm operetta; and more

Opinion and perspective essays curated by First Opinion editor Patrick Skerrett ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

To close out 2022, First Opinion presented the most-read essays of the year, published its first operetta, and more. Now it's time to ring in the New Year! May 2023 be a fruitful and fulfilling year for you. Most-read First Opinion essays of 2022 By Patrick Skerrett Hyacinth Empinado STAT published nearly 500 First Opinion essays in 2022. All are worth reading, or rereading. You can see the 5 most-read essays here. Read More The Aduhelm Operetta: 'I've got a little list' By Peter J. Pitts Alex Hogan/STAT With apologies to Gilbert & Sullivan, here's a little list (modeled on a song from "The Mikado") about the FDA's approval of Aduhelm. Read More Sponsored Insight by STAT+ Searching for the perfect gift? Get 3 months of STAT+ for $30. A STAT+ subscription gives you unlimited access to in-depth investigative journalism, groundbreaking analysis, subscriber-only newsletters, and industry event discounts. With a premium membership, you’ll get your life sciences news direct from the source. For a limited time only, get three months of STAT+ for just $30. Subscribe now. How value-based payments to clinicians can help close equity gaps By Andrew Dreyfus Adobe In Massachusetts, a value-based payment model that rewards clinicians for closing equity gaps can be a model for the nation. Read More To effectively combat diabetes, policymakers must treat obesity like other diseases By Robert Gabbay Adobe People with obesity shouldn't have to wait until they develop diabetes or other illness before Medicare covers obesity medication. Read More Sunday, January 1, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser